Transcriptomics

Dataset Information

0

Glycation-lowering compounds inhibit ghrelin signaling to reduce food intake, lower insulin resistance, and extend lifespan.


ABSTRACT: Non-enzymatic reactions in glycolysis lead to the accumulation of methylglyoxal (MGO), a reactive precursor to advanced glycation end-products (AGEs), which has been hypothesized to drive obesity and aging-associated pathologies. A combination of nicotinamide, lipoic acid, thiamine, pyridoxamine, and piperine (Gly-Low), was identified to lower glycation by reducing MGO and MGO-derived AGE, MG-H1, in mice. Administration of Gly-Low reduced food consumption, lowered body weight, improved insulin sensitivity, and increased survival in both leptin receptor-deficient (Leprdb) and wild-type C57B6/J mice. Unlike caloric restriction, Gly-Low modulated hypothalamic signaling by upregulating mTOR pathway signaling to inhibit ghrelin-mediated hunger response. Gly-Low also slowed hypothalamic aging and increased survival when administered as a late-life intervention, suggesting its potential benefits in ameliorating age-associated decline by inducing voluntary caloric restriction and reducing glycation.

ORGANISM(S): Mus musculus

PROVIDER: GSE234483 | GEO | 2025/02/28

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-05-20 | PXD032812 | Pride
2022-05-20 | PXD032832 | Pride
| PRJNA87197 | ENA
2024-01-26 | PXD037673 | Pride
| PRJNA437447 | ENA
| PRJNA695140 | ENA
2011-01-14 | E-GEOD-25896 | biostudies-arrayexpress
2015-06-23 | GSE60388 | GEO
2017-07-21 | GSE93903 | GEO
2014-09-05 | MTBLS114 | MetaboLights